Skip to main content

Table 1 Characteristics of participants who completed the assessments at Time1, Time2, and Time3

From: The effectiveness of a men-only supportive expressive group therapy intervention for psychosocial health outcomes in gastrointestinal cancer patients: a 6-month longitudinal study

Variable

T1 n (%); N = 31

T2 n (%) ; N = 24

T3 n (%) ; N = 13

Age (mean ±SD) 55.96 (±11.64)

   

18–30

1 (3.2)

1 (4.5)

1 (6.7)

31–45

5 (16.1)

5 (22.7)

2 (13.3)

46–60

12 (38.7)

8 (36.4)

6 (40.0)

61–75

13 (41.9)

8 (36.4)

6 (40.0)

Highest level of education

   

High School

5 (16.1)

3 (13.6)

2 (13.3)

College

14 (45.2)

10 (45.5)

8 (53.3)

University

12 (38.7)

9 (40.9)

5 (33.3)

Ethnicity

   

Caucasian

31 (93.9)

21 (91.3)

15 (100.0)

African

1 (3.0)

1 (4.3)

0 (0)

Asian

1 (3.0)

1 (4.3)

0 (0)

Marital Status

   

Married/common law

22 (71.0)

17 (77.3)

12 (80.0)

Single/Divorced/widowed

9 (29.0)

5 (22.7)

3 (20.0)

Employment Status

   

Employed (Fulltime/part-time)

6 (20.0)

6 (28.6)

4 (28.6)

Unemployed

24 (80.0)

15 (71.4)

10 (71.4)

Primary GI Tumour type

   

Colorectal

19 (57.6)

14 (60.9)

11 (73.3)

Esophageal

2 (6.1)

1 (4.3)

1 (6.7)

Stomach

1 (3.0)

1 (4.3)

1 (6.7)

Pancreatic

6 (18.2)

3 (13.0)

1 (6.7)

Liver

1 (3.0)

1 (4.3)

0(0)

Bile duct

1 (3.0)

1 (4.3)

0(0)

Tumour stage

   

1

2 (8.3)

2 (10.0)

2 (15.4)

2

3 (12.5)

3 (15.0)

2 (15.4)

3

6 (25.0)

5 (25.0)

5 (38.5)

4

13 (54.2)

10 (50.0)

4 (30.8)

Time since diagnosis

   

≤6 months

13 (44.8)

8 (38.1)

5 (35.7)

6.1–12 months

7 (24.1)

6 (28.6)

3 (21.4)

12.1–18 months

3(10.3)

3 (14.3)

2 (14.3)

18.1–24 months

3(10.3)

1 (4.80

1 (7.1)

>24 months

3(10.3)

3 (14.3)

5 (21.4)

Multiple cancer diagnoses

   

No

23 (74.2)

17 (77.3)

11 (73.3)

Yes

8 (25.8)

5 (22.7)

4 (26.7)

Current treatment

   

Surgery

5 (16.1)

4 (18.2)

3 (20.0)

Chemotherapy

19 (61.3)

12 (54.5)

7 (46.7)

Radiation therapy

1 (3.2)

1 (4.5)

1 (6.7)

Upcoming treatment

1 (3.2)

1 (4.5)

Past treatment

   

Surgery

16 (48.5)

11 (50.0)

9 (60.0)

Chemotherapy

10 (32.3)

9 (40.9)

8 (53.3)

Radiation therapy

6 (19.4)

5 (22.7)

5 (33.3)

  1. *T1 = baseline, T2 = 3 months and T3 = 6 months
  2. N, total number of participants